Explore comprehensive CDMO services offered by Lotte Biologics, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Lotte Biologics enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: South Korea, U.S.A.
Description: Lotte Biologics is a South Korean biopharmaceutical company established in 2022 that operates as a global contract development and manufacturing organization (CDMO). The company has a manufacturing site in Syracuse, NY, acquired from Bristol Myers Squibb, and is constructing a large-scale bio campus in Songdo, South Korea, projected to be operational in 2027. Lotte Biologics offers a range of services, including the manufacturing of antibody-drug conjugates (ADCs) and large-scale commercial biologics.
